Sexual Dysfunction In Young Women Research Articles

(213) Sexual Dysfunction in Young Women with Recurrent Urinary Tract Infections

Abstract Introduction Sexual intercourse is the risk factor most commonly associated with recurrent UTI in young women. Few studies have analyzed how rUTIs subsequently impact women’s sexual health and function Objective To investigate whether young women with rUTIs experience sexual dysfunction. Methods This is a prospective study with preliminary data collection from May – June 2022. A survey was posted on five subreddits, r/Healthyhooha, r/Interstitialcystitis, r/CUTI, r/WomensHealth and r/badwomensanatomy, which included questions on demographics, rUTI history and the 13-question Female Sexual Distress Scale-Revised (FSDS-R). Women were asked to answer the questionnaire in terms of their rUTI frequency and severity, with a scale from 0 (never) to 4 (always). Women between 18 – 35 years, not currently pregnant, and had UTIs at least every 3-4 months were included in the analysis. A score ≥ 11 indicated female sexual dysfunction (FSD). Severity of FSD was categorized as: mild (11 – 20), mild-moderate (21 – 30), moderate (31 – 40) and severe (≥41). Results One hundred fifty-one women completed the survey with 120 included in the analysis (79.5%). The average age was 27±4.9 years, majority self-identified as white (85.7%), and over half had a comorbidity (57.5%), with the most common being irritable bowel syndrome (33.3%) and autoimmune illnesses (23.2%). Half of women (50%) experienced UTIs every 3-4 months, 36.7% every month, and 13.3% every week. Women had rUTIs for an average of 9.2±8.4 years. Over half of women (59.2%) had a complication from their rUTIs, with 43% having pyelonephritis and 26.6% urosepsis. In the FSDS-r, frustration about sexual problems received the highest average score (2.9), with 42.5% of women reporting frequently and 30% reporting always feeling frustrated. Guilt over sexual problems had the second highest average score (2.7), with 35% of women frequently and 29.2% always feeling guilty. More than a third of women (40.8%) responded that they frequently avoid sex due to sexual distress. We found 111 (92.5%) participants qualified as having FSD, with an average FSDS-r score of 31.9±12.3. In terms of FSD severity, 10.8% had mild, 28% mild-moderate, 33.2% moderate and 28% severe. There was no significant difference between ethnicity, comorbidities, complications, and UTI frequency with worsening FSD score. Conclusions Many young women experience rUTIs. In our study, over 90% of young women with rUTIs qualified as having FSD measured by the FSDS-R. Our findings highlight the importance of screening women who experience rUTIs for sexual dysfunction to potentially improve their sexual health and quality of life. Disclosure No

Prevalence and association between sexual and urinary dysfunction in young women in South Brazil

Background: Issues such as urinary function, sexual function and female intimate health are still seen as forbidden in today's society, so when talking about the pelvic floor, many women do not know what it is, and the dysfunctions that occur in this structure. Urinary and sexual dysfunctions are prevalent, but studies in young populations are scarce. Aims: To survey the prevalence of sexual dysfunction (SD) and urinary incontinence (UI) in young women. Method: Investigative cross-sectional study through the Google Forms platform, using the questionnaires: FSFI and PRAFAB under descriptive statistics. Results: Participants were 54 women, mean age 24 years, average sexarch 16 years, 81 had UI (42.5% mild, 37% moderate and 1.8% severe) and 57% had SD. When combined, 46.2% of women had both disorders (20.3 mild UI and sexual dysfunction, 24% moderate UI and sexual dysfunction, and 1.8% severe UI and sexual dysfunction). Conclusion: There are associated urinary and sexual dysfunctions in young women.

MP45-12 SEXUAL DYSFUNCTION IN YOUNG WOMEN WITH RECURRENT URINARY TRACT INFECTIONS

You have accessJournal of UrologyCME1 Apr 2023MP45-12 SEXUAL DYSFUNCTION IN YOUNG WOMEN WITH RECURRENT URINARY TRACT INFECTIONS Alison Schulz, Justin Loloi, Eden Axler, and Nitya Abraham Alison SchulzAlison Schulz More articles by this author , Justin LoloiJustin Loloi More articles by this author , Eden AxlerEden Axler More articles by this author , and Nitya AbrahamNitya Abraham More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003291.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: In young women, the risk factor most commonly associated with recurrent UTIs (rUTIs) is sexual intercourse. However, few studies have subsequently analyzed the effect of rUTIs on women’s sexual health. Thus, we investigated whether young women with rUTIs experience sexual dysfunction. METHODS: Between May – Sept 2022, a survey was posted on 5 subreddits (r/Healthyhooha, r/Interstitialcystitis, r/CUTI, r/WomensHealth and r/badwomensanatomy) with questions pertaining to demographics, rUTI history and the Female Sexual Distress Scale-Revised (FSDS-r). Women answered statements in terms of rUTI frequency and severity, with a scale from 0 (never) to 4 (always). A score ≥11 indicated female sexual dysfunction (FSD), categorized as mild (11 – 20), mild-moderate (21 – 30), moderate (31 – 40) and severe (≥41). Women between 18 – 35 years, not currently pregnant, and who had UTIs at least every 3-4 months were included. Statistical analysis was performed by Kruskal–Wallis, Chi-square or Fisher’s exact tests. RESULTS: One hundred sixty-six women completed the survey and 135 (81.3%) met inclusion criteria. Average age±SD was 26.8±5 years, a majority self-identified as white (84.2%), and over half had a comorbidity (59.3%). Approximately 50% of women experienced UTIs every 3-4 months, 36% every month, and 14% every week. Women had rUTIs for an average±SD of 8.6±8.2 years. Over half (60%) experienced a UTI-related complication requiring hospitalization. In the FSDS-r portion, frustration about sexual problems received the highest average score (2.86/4) and low sexual desire had the lowest score (1.84/4). More than a third of women responded that they frequently avoid sex due to sexual distress (40.7%) and are frequently worried about sex (43.7%). We found that 124 (91.9%) participants qualified as having FSD, with an average score of 31.3±12.5. In terms of FSD severity, 12.1% had mild, 27.4% mild-moderate, 33.9% moderate and 26.6% severe. We found a significant difference between the number of UTI years and FSD severity (p = 0.032). CONCLUSIONS: In our study, over 90% of young women with rUTIs qualified as having FSD measured by FSDS-r. Our findings highlight the importance of screening women who experience rUTIs for sexual dysfunction, and providing them with tools to prevent future UTIs, hopefully avoiding long-term consequences and improving overall sexual health. Source of Funding: N/A © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e625 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Alison Schulz More articles by this author Justin Loloi More articles by this author Eden Axler More articles by this author Nitya Abraham More articles by this author Expand All Advertisement PDF downloadLoading ...

Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study

Background Self-reported sex problems among women diagnosed with reproductive and nonreproductive cancers before the age of 40 are not fully understood. This study aimed to determine sexual dysfunction in young women following a cancer diagnosis in relation to women of the general population. Furthermore, to identify factors associated with sexual dysfunction in women diagnosed with cancer. Materials and Methods A population-based cross-sectional study with 694 young women was conducted 1.5 years after being diagnosed with cancer (response rate 72%). Potential participants were identified in national quality registries covering breast and gynecological cancer, lymphoma and brain tumors. The women with cancer were compared to a group of women drawn from the general population (N = 493). Sexual activity and function were assessed with the PROMIS® SexFS. Logistic regression was used to assess differences between women with cancer and the comparison group, and to identify factors associated with sexual dysfunction. Results The majority of the women with cancer (83%) as well as the women from the comparison group (87%) reported having had sex the last month (partner sex and/or masturbation). More than 60% of the women with cancer (all diagnoses) reported sexual dysfunction in at least one of the measured domains. The women with cancer reported statistically significantly more problems than women of the comparison group across domains such as decreased interest in having sex, and vaginal and vulvar discomfort. Women with gynecological or breast cancer and those receiving more intense treatment were at particular high risk of sexual dysfunction (≥2 domains). Concurrent emotional distress and body image disturbance were associated with more dysfunction. Conclusion The results underscore the need to routinely assess sexual health in clinical care and follow-up. Based on the results, development of interventions to support women to cope with cancer-related sexual dysfunction is recommended.

Sexual dysfunctions in young university women: a cross-sectional study

OBJECTIVE: To estimate the prevalence of sexual dysfunction in young college women. METHODS: This is a descriptive analytical cross-sectional study. A total of 111 heterosexual women, students of the physiotherapy course of the Federal University of Bahia participated in this study. Each participant answered two self-administered questionnaires “Investigation of associated factors” and “Sex ratio - female version” between September and October 2019. RESULTS: A prevalence of 8% of sexual dysfunction was found in this population. The symptom of evacuatory effort was associated with worse performance / sexual satisfaction by the total SQ-F score (p=0.03) and when assessed by grouping of questions an association was found between evacuatory effort and worse arousal (p=0.01), evacuatory effort and pain (p=0.04); urinary urgency and pain (p=0.04); violence and arousal (p=0.05); and violence and less satisfaction/orgasm (p=0.02). CONCLUSION: The results suggest that there is a low prevalence of sexual dysfunction in the studied population, but there is an association between symptoms of pelvic floor dysfunction and sexual dysfunction in young women.

Sexual Dysfunction in Young Women with Type 1 Diabetes.

Introduction: Sexual dysfunctions (SD) are chronic complications that can develop due to vascular complications or autonomic neuropathy. Additionally, such complications can be of hormonal, infectious or psychogenic etiology. Objectives: The aim of study was to assess the sexual function and acceptance of the chronic disease in young sexually active women with type 1 diabetes (T1DM). Materials and methods: A total of 169 female patients with T1DM completed two standardized questionnaires, the Female Sexual Function Index (FSFI) and the Acceptance of Illness Scale (AIS). Other medical data were collected from medical history. Results: The mean FSFI score was 27.96 ± 5.00, and the mean AIS score was 29.67 ± 8.28. The score < 26 points in FSFI was obtained by 28.7% of patients. Analysis of correlation between the FSFI and the AIS showed that the higher the score on the FSFI, the higher the score on the AIS. Patients who underwent regular physical activity (55%) had a significantly higher acceptance of the disease (p = 0.0026) and reported painful intercourse significantly less frequently (p = 0.01). The value of HbA1c in the study group was 7.31 ± 1.25%. Patients with poorer glycemic control (HbA1c > 8%) obtained significantly lower scores on the FSFI (p = 0.03), whereas no differences were found on the AIS. Diabetes-related complications were observed in 25.5% of patients. The presence of chronic complications did not affect the results of the FSFI or the AIS. Patients with diabetes and hypertension had poorer functioning in the sexual sphere and had significantly lower scores on the FSFI. Past or present history of depression was reported by 36% of patients and also negatively affected acceptance of diabetes (p = 0.0015). Patients who reported recurrent urinary tract infections (17%) achieved significantly lower scores on the FSFI (p = 0.03) and showed that sex-related pain was significantly more prevalent (p = 0.02). In the case of the statement related to the embarrassment of people around the patient due to diabetes, patients with lower scores complained of SD significantly more often (p = 0.0033). Past deliveries, the type of labor, the use of contraceptives or the number of sexual partners had no influence on the overall assessment in both scales. However, in terms of desire, women who had delivered obtained higher scores (p = 0.0021). Conclusion: SD in women with T1DM may result from diabetes-related complications, hormonal disorders or recurrent genital or urinary tract infections. However, they usually have a psychological basis due to the lack of acceptance of the problems related to the treatment of diabetes.

Psychometric properties of the Female Sexual Function Index in the visual analogue scale format.

The study was conducted in three phases. In Phase 1, the instrument was adapted by two independent researchers, generating two versions, which were evaluated by a committee of six experts. The FSFI-VAS, resulting from this first phase, was used in a pilot study with 45 women. In Phase 2, the FSFI-Likert (original format) and FSFI-VAS questionnaires were administered to 246 women recruited to the study. Tests of reproducibility (test-retest/phase 3), internal consistency, discriminant validity and construct validity were applied. In Phase 1, the pilot study showed that there were no doubts and difficulties completing the FSFI-VAS. In Phase 2, the Spearman rank (validity) test showed high correlation between the total scores on the FSFI-Likert and FSFI-VAS (0.87). The results of the internal consistency test were between 0.66 and 0.88, and the results of the construct validity test indicated a good value (0.73). The discriminant validity test was also appropriate. In Phase 3, the lowest intraclass correlation coefficient value was 0.81. The FSFI-VAS has internal consistency, construct validity, discriminant validity and reproducibility adequate to assess female sexual dysfunction in young women.

Portugues

INTRODUCTION: Female sexual dysfunction is becoming a problem and an increasingly common complaint in gynecology clinics. It is defined as a disorder in the sexual response or pain associated with sexual intercourse cycle, which results in personal distress and can interfere with both the quality of life and interpersonal relationships of women. OBJECTIVE: To assess the prevalence of sexual dysfunction in young women. METHODS: This study is characterized as transversal and quantitative. 50 young women students in the health area, a private college in western Parana were interviewed. To meet the objectives the questionnaire Female Sexual Function Index (FSFI), already validated in Brazil was used. Is characterized by auto answered questionnaire consisting of 19 questions that cover six domains of sexual response: desire, arousal, lubrication, orgasm, satisfaction and pain / discomfort. Firstly the questionnaire was explained and only then answered. The participants signed a consent form agreeing to participate in the research being aimed at them a copy of this term. Among the criteria for inclusion are women 18-30 years of age who have an active sex life. The information was kept confidential. All data were indexed in a spreadsheet in Microsoft Excel 2010. RESULTS: Among the 50 women, 76% did not have any kind of sexual dysfunction, 24% had some type of sexual dysfunction. CONCLUSION: Therefore this study concludes that the study population consists of young women there was no prevalence of sexual dysfunction.

Sexual Functioning in Women with Mild and Severe Symptoms of Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth (CMT) disease is one of the most frequently inherited neurological disorders, and while it is known that individuals suffering from this condition have low quality of life, little is known about their sexual function and satisfaction. To describe the functioning on different domains of sexuality in a relatively large sample of women with CMT, provide comparisons between mildly and severely affected patients and between women with the two different types of CMT (demyelinating vs. axonal), and assess the relationship between sexual function and age of onset. Fifty-seven women (age: 18-60 years) were approached in a CMT rehabilitation clinic by a psychologist and administered the Italian version of the McCoy Female Sexuality Questionnaire (MFSQ). Data from 40 patients who had had sexual intercourse in the previous 4 weeks were analyzed. The main outcome measures are the factors MFSQ-SEX and MFSQ-PARTNER, which describe sexual functioning and sexual satisfaction with a partner, respectively. Almost 30% of women did not engage in sexual intercourse with a partner. Overall sexual problems were more prominent in younger women and tended to be lower as age increased: this pattern was different from what was reported in previous studies in comparable samples of healthy Italian women. Severity of CMT was associated with better sexual functioning in the areas of desire, arousal, orgasm, and satisfaction, with women with more severe symptoms reporting greater functioning. Women with more severe CMT symptoms reported more pain during intercourse. Age of CMT onset and type of CMT (demyelinating vs. axonal) were not associated with differences in sexual functioning. Findings point to the importance of including assessment of sexual dysfunction in young women with mild CMT symptoms and the importance of providing sex therapy or counseling to these patients.

A pilot intervention addressing sexual dysfunction after risk-reducing oophorectomy.

9644 Background: Women at high risk for ovarian cancer due to BRCA1 or BRCA2 mutation or family history are recommended to undergo prophylactic bilateral salpingo-oophorectomy (PBSO) after age 35 or completion of childbearing. This potentially life-saving surgery leads to premature menopause, frequently resulting in profound sexual dysfunction. We developed and piloted the first psychoeducational intervention for managing sexual dysfunction in young women after PBSO. Methods: This single-arm multi-modal pilot intervention study included a single half day session with educational modules about sexual health education, relaxation training, and cognitive behavioral therapy (CBT) skills to manage symptoms, followed by tailored telephone counseling. Self-report assessments, including the 19-item Female Sexual Function Index (FSFI) and a 10-item measure of sexual knowledge after PBSO were completed at baseline and two months post-intervention. Eligible women had PBSO for risk-reduction, current age ≤ 49, and endorsed at least one symptom of sexual dysfunction. Study endpoints include feasibility and effectiveness. Results: 36 women enrolled and completed pre- and post- assessments. Median age was 44 years (range 36-49) and median time since PBSO was 3.2 years (range 0.75-12.3). FSFI scores improved significantly from baseline to post-intervention for the desire (p = 0.003), arousal (p = 0.001), and satisfaction (p = 0.031) domains, as well as on the full scale score (p = 0.005). In addition, 60% of participants demonstrated improved knowledge scores about managing sexual dysfunction after PBSO following the intervention. Conclusions: The current intervention builds upon recent advances in CBT and sexual health education to address this much-neglected problem after PBSO. Results from this promising pilot intervention provide compelling preliminary data to move toward conducting a randomized clinical trial. Reducing post-PBSO distress, a valuable goal in its own right, may ultimately improve uptake of this potentially life-saving procedure in a high-risk population, as loss of sexual functioning is one of the reasons mutation carriers give for rejecting surgical risk-reduction.

Sexual dysfunction in young women with breast cancer

The objective of this study was to determine the prevalence of sexual dysfunction in young women with breast cancer in the Netherlands, and to assess the relationship between sexual dysfunction, treatment methods and treatment-related complaints. Also, the interest among women with breast cancer in receiving care for sexual dysfunction was determined. Data on sexual functioning were collected through an internet questionnaire. Respondents were included if they had been diagnosed with breast cancer within the past 6 years and were currently 45 years of age or younger. Results were compared with a representative sample of the general Dutch population Of the women who were still undergoing treatment, 64 % had a sexual dysfunction. In women who had completed treatment, this was 45 %. All assessed dysfunctions were more common among these young women with breast cancer in comparison with women in the Dutch population. Particularly, early menopause and hormone therapy caused long-term occurence of genital arousal disorder. Radical mastectomy caused long-term occurrence of female orgasmic disorder, and early menopause dyspareunia. Half of the women reported that the topic "changes in sexual functioning" had been brought up during treatment, mostly on the initiative of the health professional. Six out of 10 women with a sexual dysfunction who felt a need for care did not consult a health professional. Sexual dysfunctions are highly prevalent among young women with breast cancer. This appears to improve after treatment has been completed, but women are far from recovered. The initiative to discuss sexuality should lie with the health professional. Including sexuality within treatment guidelines will prevent women with breast cancer from being deprived of care.